Health Care

4539 posts
Nasal spray user

LTR Pharma jumps on first US sales of erectile dysfunction nasal spray ROXUS

LTR Pharma (ASX:LTP), best known for creating nasal-spray-based viagra alternatives, jumped +10% on Tuesday after fillings the first prescriptions

AFT Pharmaceuticals unveils double digit revenue growth in 1H FY27

AFT Pharmaceuticals has achieved sustained double-digit revenue growth for 1H FY27 and remains on track to…
The Market Online Video

AFT builds momentum across markets as international growth takes focus

AFT Pharmaceuticals (ASX: AFP) is continuing to see strong growth across its established Australian and New Zealand markets, while international and Asian
Close up of CSL sign on the office building in Melbourne, Victoria, Australia.

CSL teams up with Swiss Alentis for kidney and liver drug in A$2B deal

CSL Ltd (ASX:CSL) has announced it’s teaming up with Basel-headquartered Alentis Therapeutics to ‘co-develop’ a drug to treat rare

Artrya lands significant US Huntsville Hospital Health System commercial agreement

Artrya has signed a five-year commercial agreement with Huntsville Hospital Health System (HH Health) in the…
3D image of ovarian cancer

Cleo Diagnostics patents ovarian cancer test IP; shares jump on low liquidity

Ovarian cancer detection biotech Cleo Diagnostics (ASX: COV) has seen shares jump towards +4% on Wednesday as it patents
Exit sign

Paradigm Biopharma draws ire as administrators called in one week after suspension

Paradigm Biopharma (ASX:PAR) has made the sad move of calling in voluntary administrators on Wednesday after the latest data
Nasal spray

Firebrick Pharma flags intention to enter US market with nasal iodine product

Firebrick Pharma (ASX:FRE) has formally earmarked its ambitions to penetrate the US retail market with its Nasodine (nasal iodine)

AFT Pharmaceuticals opens Japan opportunity for Maxigesic IV

AFT Pharmaceuticals (ASX: AFP) has secured an exclusive development, licensing and supply agreement for its Maxigesic® IV (also known as Combogesic® IV)

All eyes on Prescient Therapeutics as it enters into trading halt

Prescient Therapeutics entered into a trading halt this morning and opened a placement opportunity for sophisticated…